DUBLIN, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ:DAVI) ("Davion" or the "Company"), a developer of non-invasive health monitoring technologies, announces that it has entered into
DUBLIN, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ:DAVI) ("Davion" or the "Group"), a developer of non-invasive health monitoring technologies, announces that it has entered into
DUBLIN, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ:DAVI) ("Davion" or the "Company"), a next-generation digital healthcare company developing proprietary health monitoring
Ordinary shares expected to commence trading on Nasdaq Global Market on Thursday 22 October 2026 under ticker "DAVI"Glenn Williams appointed Chief Executive Officer and Jeremy North Chief Operating Officer,
